Revenue Spike Expected for GW Pharmaceuticals in 2019
On its fiscal 2018 fourth-quarter earnings conference call, GW Pharmaceuticals (GWPH) announced the change of the end of its fiscal year from September 30 to the calendar year’s end on December 31. Analysts expect GW Pharmaceuticals to report revenue of $131.30 million in 2019, a YoY (year-over-year) rise of 930.86%. The company is also expected to report revenue of $421.71 million in 2020, a YoY rise of 221.18%.